Autoplaque vs Vivid T8

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Autoplaque

by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

Vivid T8

by GE HealthCare

AI Verdict

Autoplaque is an AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, focusing on heart attack risk prediction. In contrast, the GE Vivid T8 is a hybrid cardiovascular ultrasound system that uses AI for workflow efficiency in its Ultra Edition, providing comprehensive ultrasound imaging for a broader range of cardiac functions. While both leverage AI for cardiac assessment, Autoplaque specializes in CT-based plaque analysis for risk stratification, whereas the Vivid T8 focuses on ultrasound imaging and AI-assisted measurements for general cardiac diagnostics and workflow.

Choose Autoplaque if…

Choose Autoplaque if your primary need is a detailed, AI-powered quantitative analysis of coronary plaques and luminal stenoses from existing CT angiography images. This workstation-based software is best suited for precise heart attack risk prediction and guiding treatment strategies based on comprehensive plaque characterization and automated vessel segmentation.

View Autoplaque →

Choose Vivid T8 if…

Choose GE HealthCare's Vivid T8 if you require an advanced, cost-effective cardiovascular ultrasound system for real-time, dynamic imaging and AI-powered diagnostic assistance during live patient examinations. This on-premise hardware solution excels in immediate assessment of cardiac function, automated measurements, and streamlined workflows across cardiology and shared service settings.

View Vivid T8 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Autoplaque	Vivid T8
Pricing	Unknown	Contact vendor
Deployment	Workstation-based post-processing application, runs on Windows or Mac OS.	On-premise (console-based medical device)
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Autoplaque is a workstation-based software with automated segmentation that is reviewable and editable by clinicians, suggesting a user-friendly design for specialists. The GE Vivid T8 is a console-based ultrasound system with an intuitive control panel, customizable touch screen, and AI-based tools for workflow efficiency, also indicating a strong focus on usability. Both tools appear to prioritize ease of use within their respective domains.

Clinical Value

Autoplaque

Autoplaque offers AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, directly aiding in heart attack risk prediction and treatment guidance. This provides critical diagnostic information for personalized preventive cardiology. The Vivid T8, while a robust cardiovascular ultrasound system with advanced quantitative tools and AI for workflow, primarily focuses on imaging and efficiency rather than direct risk prediction from plaque analysis.

Pricing & Value

Vivid T8

The GE Vivid T8 offers transparent pricing for refurbished units starting at $22,800 and includes 3 years of service coverage, providing a clear understanding of the initial investment and long-term support. Autoplaque's pricing is not disclosed, making it difficult for potential buyers to assess its value proposition without direct inquiry.

Enterprise Readiness

Vivid T8

The GE Vivid T8, as a medical device from a large, established company like GE HealthCare, is designed for reliability, robustness, and mobility in diverse clinical settings, including hospitals and private practices. It also emphasizes cybersecurity and patient data privacy with its SonoDefense approach. Autoplaque is workstation-based software, and while FDA-cleared and backed by Cedars-Sinai, specific details on its enterprise deployment, scalability, and comprehensive security features beyond general HIPAA compliance are not as extensively detailed in the provided information.

Innovation

Autoplaque

Autoplaque demonstrates strong innovation by applying AI for quantitative analysis of coronary plaques and luminal stenoses from CT angiography, directly contributing to heart attack risk prediction. This represents a cutting-edge application in preventive cardiology. While the Vivid T8 Ultra Edition incorporates AI for workflow efficiency and advanced quantitative tools, its core offering is an ultrasound system, and its AI features primarily enhance existing imaging capabilities rather than introducing a fundamentally new diagnostic approach.

Support & Docs

Vivid T8

GE HealthCare provides extensive documentation for the Vivid T8, including user manuals and service manuals, and offers a clinical answer center for support. The Vivid T8 also comes with 3 years of service coverage. Information regarding specific support services or detailed documentation for Autoplaque is not readily available in the provided facts or web search results, making it difficult to assess its offerings in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Autoplaque	Vivid T8
Name	Autoplaque	Vivid T8
Company	Cedars-Sinai Medical Center: AIM	GE HealthCare
Description	Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.	The GE Vivid T8 is a hybrid cardiovascular ultrasound system offering advanced imaging capabilities for cardiac and shared services, designed for reliability and ease of use in diverse clinical settings. It includes AI-based tools for workflow efficiency in its Ultra Edition.
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI
Specialties	Cardiology, Radiology	Cardiology, Radiology
Key Features	AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology from CT Angiographic images; Workstation-based post-processing application; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views; Measurement of vessel diameter and area	Hybrid cardiovascular and shared-service ultrasound capabilities; 19-inch LCD monitor (21.5-inch for Ultra Edition) and 8.4-inch LCD touchscreen (10.1-inch multi-touch for Ultra Edition); 4 active transducer ports; Advanced quantitative tools (e.g., Tissue Velocity Imaging, AutoEF, SmartStress, AFI, Strain/Strain Rate Imaging, AutoIMT); Rugged, durable, and mobile design with extensive stress testing; AI-based tools for workflow efficiency (Vivid T8 Ultra Edition); DICOM and EchoPAC compatibility for image analysis and sharing; Comprehensive cardiovascular scanning applications

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and Vivid T8.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate with existing EHR systems and imaging archives for a streamlined workflow?

Autoplaque is a workstation-based post-processing application that analyzes CT angiography images, suggesting it would integrate by importing DICOM images from your PACS and exporting its analysis results, likely as structured reports or new DICOM objects, back to your EHR or PACS. The GE Vivid T8 is a console-based ultrasound system with DICOM and EchoPAC compatibility, indicating it can directly store and transmit images and reports to your PACS and potentially integrate with your EHR for patient demographics and order management.

What is the accuracy and sensitivity of Autoplaque in detecting and characterizing coronary plaques and stenoses, and how does this compare to manual interpretation?

Autoplaque provides AI-powered quantitative analysis of atherosclerotic plaque and luminal stenoses from CT angiography images, aiming to aid in heart attack risk prediction and treatment guidance. It offers automated vessel, plaque, and lumen segmentation that is reviewable and editable by the clinician, suggesting a high degree of accuracy and the ability for physicians to validate and refine the AI's findings.

Given that Autoplaque is developed by Cedars-Sinai AIM, what kind of ongoing support and updates can a physician expect, and how does this compare to a larger vendor like GE HealthCare for the Vivid T8?

Autoplaque, being developed by Cedars-Sinai AIM, may offer support directly from the development team, potentially providing in-depth clinical and technical expertise. GE HealthCare, as a larger vendor, typically offers comprehensive service coverage, with the Vivid T8 including 3 years of service coverage, implying a more standardized and extensive support infrastructure.

What specific features are available for auditing and tracking the use of these tools and the modifications made to their outputs?

Autoplaque's feature of automated segmentation being 'reviewable and editable by clinician' implies that there would be an audit trail to track any clinician modifications to the AI's initial analysis. For the Vivid T8, while not explicitly stated, medical imaging systems typically maintain logs of studies performed and user access, which can serve as an audit trail for system usage.

How do these tools support multi-site rollouts, particularly concerning consistent performance and user training across different clinical environments?

Autoplaque, as workstation-based software, could be deployed across multiple sites on individual workstations, requiring consistent software installation and potentially centralized image access. The Vivid T8, being a console-based medical device, would require individual unit deployment at each site, with GE HealthCare likely offering standardized training and support for consistent implementation across different locations.

Beyond standard security measures, what additional security postures do these tools employ to protect patient data, especially given the sensitive nature of cardiac imaging?

Autoplaque's description focuses on its analytical capabilities, and while not explicitly detailing security beyond general compliance, as a medical software handling sensitive data, it would be expected to adhere to robust data encryption and access control. The Vivid T8, as a medical imaging system, would rely on the security protocols of the healthcare environment it operates within, including network security and access controls for patient data on the device itself and during transmission via DICOM.